Industry News
Pharmaceutical Industry News
A Los Angeles court found Johnson…
A Los Angeles court found Johnson & Johnson liable in a case brought by a woman who died from mesothelioma in 2021. With its decision, a jury ordered the company to pay $966 million to
Novartis polled more than 3,000…
Novartis polled more than 3,000 women to gauge how their thoughts and feelings about their breasts impact their breast health, discovering five findings that could offer insight into what's needed to encourage more conversations on
AbbVie is going back to school to…
AbbVie is going back to school to support patients with inflammatory bowel disease, enrolling “Abbott Elementary” star Tyler James Williams for a new campaign aimed at sparking deeper conversations about long-term IBD treatment goals.
Brad Bacon discusses access…
Brad Bacon discusses access challenges, direct-to-patient shifts and the role of trust in care
Less than two months after OXB…
Less than two months after OXB revealed a plan to expand its operations in the U.S., the U.K.-based cell and gene therapy manufacturer has purchased a viral vector plant in North Carolina from National Resilience
Join Fierce Pharma as we sit down…
Join Fierce Pharma as we sit down with industry innovators to explore the most impactful strategies, cutting-edge insights, and collaborative approaches shaping the future of pharma engagement.
The specialty pharmacy industry is…
The specialty pharmacy industry is in a state of transformation, fueled by the rise of complex, innovative therapies and the critical need for more robust patient support.
Gilead Sciences has struck accords…
Gilead Sciences has struck accords with Lupin, Cipla and Laurus Labs to delay the entry of any Biktarvy copycats in the U.S. until April 1, 2036. Gilead had previously estimated that Biktarvy’s U.S. market exclusivity
Even as President Donald Trump…
Even as President Donald Trump directed the FDA in early September to begin cracking down on direct-to-consumer pharmaceutical advertising, spending on TV drug ads still ratcheted up compared to the preceding few months.
The CDC’s updated COVID guidelines…
The CDC's updated COVID guidelines put the vaccines under an individual-based decision-making practice as opposed to the agency's prior universal recommendation.
A California judge has ruled that…
A California judge has ruled that Biogen owes Roche $124 million in royalties for its use of intellectual property developed more than 40 years ago by the Swiss company’s subsidiary Genentech that covered a process
Peter Stark says quality projected…
Peter Stark says quality projected data drives accurate forecasting, better engagement and earlier diagnoses
Vice president of strategy…
Vice president of strategy outlines key considerations for data and go-to-market strategies
Amgen has joined the wave of major…
Amgen has joined the wave of major drugmakers setting up direct-to-consumer programs amid President Donald Trump’s call for more DTC options to lower U.S. drug prices.
The company will work with new…
The company will work with new local contract manufacturers in India to boost supply of its key medicines.
AstraZeneca and Daiichi Sankyo’s…
AstraZeneca and Daiichi Sankyo’s Datroway has become the first cancer drug to show an overall survival benefit against chemotherapy for certain patients with a particularly aggressive form of breast cancer. In a phase 3 trial,
Myeloid Therapeutics’ name no…
Myeloid Therapeutics’ name no longer fits its pipeline. Having expanded beyond the eponymous myeloid cells, the biotech has rebranded as Create Medicines and committed to an R&D strategy that spans in vivo multi-immune programming.
What to Know as Gisèle Pelicot Returns to Court for Man’s Appeal
The Frenchwoman who became a feminist icon will confront one of the men convicted after her husband drugged her and invited them to rape her over nearly 10 years.
Costco to Sell Ozempic and Wegovy, Weight-Loss Wonder Drugs
Costco members will pay $499 a month out of pocket, the same price offered at CVS and Walmart, and on the manufacturer’s direct-to-consumer website.
Why Brittle Bones Aren’t Just a Woman’s Problem
More men are now living long enough to develop osteoporosis. But few are aware of the risk, and fewer still are screened and treated.